Skip to content
Beacon

NVOHNovo Nordisk A/S (B Shares) ADRhedged

Grow my money1y track recordRanked #1,841 of 2,999 in this goal

Seeks to provide investment results that correspond generally to the total return of the ordinary shares of Novo Nordisk A/S (B Shares) in its local market.

By ADRH · Launched 2025

Annual Cost

0.19%

#838 of 5,861 · low cost

Fund Size

$4M

#5,291 of 5,861 · small

Return (1Y)Goal

-3.3%

Track Record

1 year

#3,984 of 5,861 · young

Performance

Total-return NAV · USD
Growth of $10,000
$10,379+3.8%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Single stock

What it actually holds

By weight

Concentration

single-stock bet — holdings shown are derivatives collateral, not diversification

Novo Nordisk A/S
93.8%
DREYFUS TRSRY SECURITIES
3.8%
CANADIAN IMPERIAL BANK OF COMMERCE
-0.4%

Asset allocation

Stocks
97.3%
Cash
2.7%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
45.1%High

Year-on-year price swings

Max drawdown
-61.6%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks to provide investment results that correspond generally to the total return of the ordinary shares of Novo Nordisk A/S (B Shares) in its local market.
Strategy
Invests at least 95% of net assets in ADRs of Novo Nordisk A/S (B Shares) and uses a currency swap to hedge against fluctuations in the exchange rate between the U.S. dollar and the Danish krone. The Series does not seek to replicate the performance of a specified index and is non-diversified.
Inception date
January 6, 2025
Fund family
ADRH

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Single stock
Warning

A fund-sized fee to own one company

This wraps a single stock, usually with an options overlay on top. You pay 0.50% to 1.00% a year for exposure you could hold directly, and any income comes from selling off your own upside. Owning the share itself costs less and keeps that upside intact.

Sources: Israelov & Nielsen, 'Covered Calls Uncovered' (Financial Analysts Journal 2015)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at NVOH. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-04